Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.
Width of 3. Ventricle: reference values and clinical relevance in a cohort of patients with relapsing remitting multiple sclerosis.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
Nongenomic actions of neurosteroid pregnenolone and its metabolites.
Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.
Anti-Aquaporin-4 Antibody Positivity in Neuromyelitis Optica Is Associated with Lesion Activity.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
Determinants of disability in multiple sclerosis: an immunological and MRI study.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
[History of Guillain-Barré Syndrome].
Caffeine treatment aggravates secondary degeneration after spinal cord injury.
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
bFGF Protects Pre-oligodendrocytes from Oxygen/Glucose Deprivation Injury to Ameliorate Demyelination.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.

Pages